Integra Lifesciences Holdings (IART) Cash & Equivalents Growth (1y) (2010 - 2026)
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 72.43% |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | -1.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.61% |
| Mar 31, 2026 | -0.96% |
| Dec 31, 2025 | -4.60% |
| Sep 30, 2025 | 7.90% |
| Jun 30, 2025 | 1.24% |
| Mar 31, 2025 | -59.60% |
| Dec 31, 2024 | -10.86% |
| Sep 30, 2024 | -21.38% |
| Jun 30, 2024 | -30.39% |
| Mar 31, 2024 | 92.57% |
| Dec 31, 2023 | -39.47% |
| Sep 30, 2023 | -46.53% |
| Jun 30, 2023 | -30.85% |
| Mar 31, 2023 | -24.50% |
| Dec 31, 2022 | -11.06% |
| Sep 30, 2022 | 8.87% |
| Jun 30, 2022 | 12.52% |
| Mar 31, 2022 | -0.46% |
| Dec 31, 2021 | 9.21% |
| Sep 30, 2021 | 18.66% |